Company Profile
Updated: 17-SEP-09Alethia BioTherapeutics
International Private company
140 Ave. du President - Kennedy Ste. SB5100, Montreal, QC H2X 1Y4, Canada
(514)8587666, (514)8585333 fax, http://www.alethiabio.com
Primary SIC: Commercial Physical & Bio Research, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Services: Biotechnology company engaged in the discovery and development of therapeutics for the treatment of cancer and cancer-associated complications.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Alethia Biotherapeutics Strengthens its Board of Directors.
Marketwire Canada; 12/15/2009; 822 words; ...Dec 15, 2009 (Marketwire via COMTEX) -- Alethia Biotherapeutics Inc., a privately held biotechnology company...I am very pleased to join the board of Alethia Biotherapeutics. Alethia is a very exciting company which I believe...
Alethia Biotherapeutics Inc. Announces in-Licensing of a Peptide for Imaging of Solid Tumors in vivo and Positive Pre-Clinical Results of AB-16B5 in Prostate and Breast Cancer.
Marketwire Canada; 12/7/2009; 1081 words; ...Marketwire via COMTEX) -- Alethia Biotherapeutics Inc., a privately held...Executive Officer. About Alethia Biotherapeutics Inc. Alethia is a privately...therapeutics. SOURCE: Alethia Biotherapeutics Inc. Alethia Biotherapeutics...
Sheila A. Brown and Louise Proulx Appointed to the Board of Directors of the Canada Foundation for Innovation.
Marketwire Canada; 9/8/2009; 857 words; ...has been a member of several boards of directors, and is currently Director of GeminX Pharmaceuticals Inc., Alethia Biotherapeutics, Inc. and Diagnocure Inc. She has also recently been elected to the board of Genome Quebec. A complete list...
Other News To Note.
BIOWORLD Today; 5/7/2009; 1027 words; ...SR is being developed for multiple sclerosis. Alethia Biotherapeutics, of Montreal, has signed an agreement to license...Research Institute. Under the terms of the agreement, Alethia obtains a family of high-affinity monoclonal antibodies...
Alethia Biotherapeutics Inc.-Company Report.
M2 Presswire; 1/27/2009; 503 words; ...January 2009-www.companiesandmarkets.com: Alethia Biotherapeutics Inc.-Company Report(C)1994-2009 M2 COMMUNICATIONS...companiesandmarkets.com adds new report: Alethia Biotherapeutics Inc.-Company Report Private Company Reports...
Recent News Articles
- Alethia BioTherapeutics Inc. Announces the Filing of a Patent Application for its Bone-related Validated Targets.
Business Wire - December 19, 2005 - Alethia BioTherapeutics Inc. Appoints Mr. Yves Cornellier as President and Chief Executive Officer.
Business Wire - August 03, 2005 - Alethia BioTherapeutics, Inc., is Issued a European Patent For Its Target Discovery Technology.
Business Wire - July 19, 2005
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning